Portfolio company NOWDiagnostics received FDA De Novo marketing authorization for its First To Know OTC syphilis test.
NOWDiagnostics develops and manufactures over-the-counter and point-of-care diagnostic tests that yield results in minutes, focusing on making healthcare more accessible through in-home testing
NOWDiagnostics develops and manufactures over-the-counter and point-of-care diagnostic tests that yield results in minutes, focusing on making healthcare more accessible through in-home testing.